Trevi Therapeutics
TRVI
#4819
Rank
A$3.01 B
Marketcap
A$21.13
Share price
-5.16%
Change (1 day)
74.74%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2026 (TTM): -A$70.6 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$61.62 Million, an increase over its 2024 earnings that were of -A$67.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$70.6 Million14.57%
2025 -A$61.62 Million-8.34%
2024 -A$67.23 Million67%
2023 -A$40.26 Million2.43%
2022 -A$39.3 Million-14.45%
2021 -A$45.94 Million1.36%
2020 -A$45.33 Million23.64%
2019 -A$36.66 Million27.54%
2018 -A$28.75 Million